Endo International is the latest drugmaker to file for chapter 11 bankruptcy protection in connection with opioid litigation in the US, after agreeing a $6 billion deal with creditors that ...

Endo Pharmaceuticals has removed its Opana ER opioid painkiller from the US market at the request of the FDA.